Fig. 5: The detailed workflow of deep-learning (DL)-assisted revision of stromal tumor-infiltrating lymphocyte (sTIL) by pathologists. | npj Breast Cancer

Fig. 5: The detailed workflow of deep-learning (DL)-assisted revision of stromal tumor-infiltrating lymphocyte (sTIL) by pathologists.

From: Deep learning model improves tumor-infiltrating lymphocyte evaluation and therapeutic response prediction in breast cancer

Fig. 5

Pathologists and DL independently performed the sTIL assessment (Step 1 and 2). If there was more than a 10% difference between each pathologist and DL results (Step 3), the pathologist performed a reassessment with the DL-powered model assistance (Step 4).

Back to article page